SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Black Bird Biotech, Inc. – ‘10-Q’ for 9/30/22 – ‘EXCEL’

On:  Monday, 11/14/22, at 4:25pm ET   ·   For:  9/30/22   ·   Accession #:  1477932-22-8521   ·   File #:  0-52828

Previous ‘10-Q’:  ‘10-Q’ on 8/23/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/22/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/22  Black Bird Biotech, Inc.          10-Q        9/30/22   75:46M                                    Discount Edgar/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    630K 
 2: EX-10.1     Securities Purchase Agreement                       HTML     27K 
 3: EX-10.2     Security Agreement                                  HTML     27K 
 4: EX-10.3     Securities Purchase Agreement                       HTML     22K 
 5: EX-10.4     Senior Secured Promissory Note                      HTML     25K 
 6: EX-10.5     Convertible Promissory Note                         HTML     22K 
 7: EX-10.6     Warrant                                             HTML     22K 
 8: EX-10.7     Warrant                                             HTML     22K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
17: R1          Cover                                               HTML     71K 
18: R2          Consolidated Balance Sheets                         HTML    112K 
19: R3          Consolidated Balance Sheets (Parenthetical)         HTML     43K 
20: R4          Consolidated Statements of Operations (Unaudited)   HTML    117K 
21: R5          Consolidated Statement of Changes in Stockholders'  HTML    107K 
                Equity (Deficit) (Unaudited)                                     
22: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    104K 
23: R7          Basis of Presentation and Nature of Operations      HTML     26K 
24: R8          Summary of Significant Accounting Policies and      HTML     34K 
                Going Concern                                                    
25: R9          Coronavirus Pandemic                                HTML     22K 
26: R10         Concentration of Credit Risk                        HTML     22K 
27: R11         Convertible Promissory Notes Third Parties          HTML     65K 
28: R12         Common Stock                                        HTML     49K 
29: R13         Preferred Stock                                     HTML     22K 
30: R14         Warrants                                            HTML     25K 
31: R15         Securitis Exchange Agreements                       HTML     30K 
32: R16         Related Party Transactions                          HTML     36K 
33: R17         Loans Payable Related Parties                       HTML     27K 
34: R18         Amendments of Articles of Incorporation             HTML     31K 
35: R19         New Mitexstream Agreement                           HTML     28K 
36: R20         Asset Purchase Agreement                            HTML     23K 
37: R21         Intangible Asset                                    HTML     22K 
38: R22         Stockholder Receivable                              HTML     22K 
39: R23         Subsequent Events                                   HTML     24K 
40: R24         Summary of Significant Accounting Policies and      HTML     50K 
                Going Concern (Policies)                                         
41: R25         Convertible Promissory Notes Third Parties          HTML     41K 
                (Tables)                                                         
42: R26         Common Stock (Tables)                               HTML     34K 
43: R27         Securities Exchange Agreements (Tables)             HTML     28K 
44: R28         Related Party Transactions (Tables)                 HTML     26K 
45: R29         New Mitexstream Agreement (Tables)                  HTML     26K 
46: R30         Summary of Significant Accounting Policies and      HTML     29K 
                Going Concern (Details Narrative)                                
47: R31         Concentration of Credit Risk (Details Narrative)    HTML     22K 
48: R32         Convertible Promissory Notes Third Parties          HTML     31K 
                (Details)                                                        
49: R33         Convertible Promissory Notes Third Parties          HTML     37K 
                (Details 1)                                                      
50: R34         Convertible Promissory Notes Third Parties          HTML     43K 
                (Details 2)                                                      
51: R35         Convertible Promissory Notes Third Parties          HTML     27K 
                (Details 333)                                                    
52: R36         Convertible Promissory Notes Third Parties          HTML    211K 
                (Details Narrative)                                              
53: R37         Common Stock (Details)                              HTML     29K 
54: R38         Common Stock (Details 1)                            HTML     29K 
55: R39         Common Stock (Details 2)                            HTML     29K 
56: R40         Common Stock (Details Narrative)                    HTML     91K 
57: R41         Preferred Stock (Details Narrative)                 HTML     24K 
58: R42         Warrants (Details Narrative)                        HTML     53K 
59: R43         Securities Exchange Agreements (Details )           HTML     34K 
60: R44         Securities Exchange Agreements (Details Narrative)  HTML     36K 
61: R45         Related Party Transactions (Details)                HTML     36K 
62: R46         Related Party Transactions (Details Narrative)      HTML     82K 
63: R47         Loans Payable Related Parties (Details Narrative)   HTML     37K 
64: R48         Amendment of Articles of Incorporation (Details     HTML     29K 
                Narrative)                                                       
65: R49         New Mitexstream Agreement (Details)                 HTML     34K 
66: R50         Asset Purchase Agreement (Details Narrative)        HTML     34K 
67: R51         Intangible Asset (Details Narrative)                HTML     23K 
68: R52         Stockholder Receivable (Details Narrative)          HTML     22K 
69: R53         Subsequent Events (Details Narrative)               HTML     35K 
70: R54         Convertible Promissory Notes Third Parties          HTML     37K 
                (Details 3)                                                      
73: XML         IDEA XML File -- Filing Summary                      XML    124K 
71: XML         XBRL Instance -- bbbt_10q_htm                        XML    993K 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX     86K 
14: EX-101.CAL  XBRL Calculations -- bbbt-20220930_cal               XML    133K 
16: EX-101.DEF  XBRL Definitions -- bbbt-20220930_def                XML    531K 
13: EX-101.LAB  XBRL Labels -- bbbt-20220930_lab                     XML    809K 
15: EX-101.PRE  XBRL Presentations -- bbbt-20220930_pre              XML    716K 
12: EX-101.SCH  XBRL Schema -- bbbt-20220930                         XSD    193K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              294±   369K 
75: ZIP         XBRL Zipped Folder -- 0001477932-22-008521-xbrl      Zip    132K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/24/23  Black Bird Biotech, Inc.          S-1/A                 90:6.3M                                   Discount Edgar/FA
 2/07/23  Black Bird Biotech, Inc.          S-1                   94:10M                                    Discount Edgar/FA
Top
Filing Submission 0001477932-22-008521   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:24:30.1pm ET